Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-021611

Chief Commercial Officer sold 2,050 shares at $84.65 ($173,533)

  • Chief Commercial Officer acquired 2,050 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hoerter Steven L. Chief Commercial Officer 2018-03-22 Option exercise +2,050 $39.76 $81,508 2,050 D: show line 1 in the form
Hoerter Steven L. Chief Commercial Officer 2018-03-22 Sale −2,050 $84.65 $173,533 0 D: show line 2 in the form
Open-market sales · 2,050 sh · avg $84.65 · $173,533

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hoerter Steven L. Chief Commercial Officer 2018-03-22 Option exercise · Stock option (right to buy) −2,050 70,900 D: show line 3 in the form
Loading xslF345X03/doc4.xml…